Literature DB >> 5577486

Cardiovascular effects of levodopa.

L I Goldberg, T L Whitsett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5577486     DOI： 10.1002/cpt1971122part2376

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  10 in total

1.  Autonomic Nervous System Dysfunction in Parkinson's Disease.

Authors:  Theresa A. Zesiewicz; Matthew J. Baker; Mervat Wahba; Robert A. Hauser
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

Review 2.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 3.  Antiparkinsonian drugs: pharmacological and therapeutic aspects.

Authors:  D B Calne; J L Reid
Journal:  Drugs       Date:  1972       Impact factor: 9.546

4.  [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors:  W Gehlen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-04-09

5.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 7.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

8.  Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors:  A Dalvi; B Ford
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

9.  On the mechanism of L-dopa-induced postural hypotension in the cat.

Authors:  K M Dhasmana; B A Spilker
Journal:  Br J Pharmacol       Date:  1973-03       Impact factor: 8.739

10.  Effectiveness and safety of topical levodopa in a chick model of myopia.

Authors:  Kate Thomson; Cindy Karouta; Ian Morgan; Tamsin Kelly; Regan Ashby
Journal:  Sci Rep       Date:  2019-12-04       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.